Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L10 pseudogene 19 (RPL10P19)
- Target
- RPL10P19
- Molecular classification
- Other (Pseudogene)
01
Overview
RPL10P19 (ribosomal protein L10 pseudogene 19) is classified as a *pseudogene*, meaning it is a DNA sequence resembling the ribosomal protein L10 gene (RPL10) but lacking the capability to code for a functional protein[2]. Pseudogenes are typically nonfunctional remnants of related functional genes, generated by gene duplication or retrotransposition events. RPL10P19 does not produce a functional ribosomal or enzymatic protein and is not implicated in therapeutic targeting, biological signaling, or known pathology. No common aliases, interacting drugs, disease associations, or biomarkers are recorded for this pseudogene. It primarily serves as a genomic record of gene evolution and is not used as a pharmacological or experimental target[2]. If additional references appear to mention disease or regulatory associations for this pseudogene, they are either speculative, not supported by current evidence, or possibly confused with the functional RPL10 or its known functional homologs. The presence of "pseudogene" in the name indicates it is not a protein-coding gene and is therefore not a canonical target for therapy or drug development.
- Other names
- RPL10P19ribosomal protein L10 pseudogene 19
02
Mechanism of action
None
03
Biological functions
None (pseudogenes are generally non-coding and do not have biological functions in protein synthesis or signaling)
04
Disease associations
None known (pseudogenes typically do not have direct disease roles unless they contribute to gene regulation or non-coding RNA effects, and there is no evidence for RPL10P19 in this context as of current knowledge)
Beyond the preview
Go deeper on Ribosomal protein L10 pseudogene 19 (RPL10P19).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L10 pseudogene 19 (RPL10P19).